These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 9658674)

  • 1. Intradermal hepatitis B vaccination: five-year follow-up.
    Leonardi S; Barone P; Musumeci S
    Pediatr Infect Dis J; 1995 Aug; 14(8):716-7. PubMed ID: 8532435
    [No Abstract]   [Full Text] [Related]  

  • 2. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 3. Protective level of antibody induced by hepatitis B vaccine.
    Subramanyam V; Ramesh S
    Indian Pediatr; 1998 Aug; 35(8):800-1. PubMed ID: 10216582
    [No Abstract]   [Full Text] [Related]  

  • 4. Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.
    Frey S; Dagan R; Ashur Y; Chen XQ; Ibarra J; Kollaritsch H; Mazur MH; Poland GA; Reisinger K; Walter E; Van Damme P; Braconier JH; Uhnoo I; Wahl M; Blatter MM; Clements D; Greenberg D; Jacobson RM; Norrby SR; Rowe M; Shouval D; Simmons SS; van Hattum J; Wennerholm S; Gress JO
    J Infect Dis; 1999 Dec; 180(6):2018-22. PubMed ID: 10558961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An early-type hypersensitivity (ETH) to hepatitis B surface antigen as a quick and economic screening test for a vaccination program.
    Barone P; Leonardi S; Oggiano R; Musumeci S
    Ann Ig; 1998; 10(2):121-4. PubMed ID: 9658674
    [No Abstract]   [Full Text] [Related]  

  • 6. A delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) and intradermal hepatitis B vaccination.
    Nagafuchi S; Kashiwagi S; Hayashi J; Katsuta H; Ikematsu H; Harada M
    Fukuoka Igaku Zasshi; 2004 Dec; 95(12):305-13. PubMed ID: 15732372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
    Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Active immunoprophylaxis of type B viral hepatitis].
    Spiga L; Mela GS
    G Clin Med; 1984; 65(5-6):237-49. PubMed ID: 6236122
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines.
    Zuckerman JN
    J Med Virol; 2006 Feb; 78(2):169-77. PubMed ID: 16372285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis B immunization for newborn infants of hepatitis B surface antigen-positive mothers].
    Cowan SA; Qureshi KM
    Ugeskr Laeger; 2007 Oct; 169(41):3471-4. PubMed ID: 17967274
    [No Abstract]   [Full Text] [Related]  

  • 11. Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen.
    Schirmbeck R; Reimann J
    Biol Chem; 2001 Apr; 382(4):543-52. PubMed ID: 11405219
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.